Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1975 Sep;12(3):606-13.
doi: 10.1128/iai.12.3.606-613.1975.

Neutralizing antibody responses to varicella-zoster virus

Neutralizing antibody responses to varicella-zoster virus

N J Schmidt et al. Infect Immun. 1975 Sep.

Abstract

Neutralization of varicella-zoster (V-Z) virus by human sera and immune rhesus monkey sera was enhanced by fresh guinea pig complement. There was no marked difference in the degree to which complement enhanced neutralization by sera from current V-Z virus infections and sera from long-past varicella infections. Immunoglobulin G neutralizing antibody in sera from varicella cases was enhanced by complement to a slightly higher degree than was immunoglobulin M (IgM) antibody, and immunoglobulin G neutralizing antibody in immune monkey sera was enhanced to a much greater degree than was IgM antibody. There was a rapid decline in the complement requirement of IgM neutralizing antibodies over the course of immunization of the rhesus monkeys. V-Z neutralizing antibody titers in the presence of complement were higher than complement-fixing titers of the same sera in all groups of individuals studied. IgM neutralizing antibody for V-Z virus was demonstrable in all cases of varicella but in only 1 of 22 zoster cases, and V-Z IgM neutralizing antibody was not detectable in primary herpes simplex virus infections in which heterotypic antibody titer rises occurred to V-Z virus. Complement-fixing antibody for V-Z virus was absent in 19S serum fractions which contained IgM neutralizing antibody for the virus.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1958 Dec 1;108(6):843-68 - PubMed
    1. J Lab Clin Med. 1965 Sep;66(3):403-12 - PubMed
    1. Lancet. 1963 Nov 9;2(7315):982-3 - PubMed
    1. J Immunol. 1964 Apr;92:501-6 - PubMed
    1. Proc Soc Exp Biol Med. 1964 May;116:144-9 - PubMed

LinkOut - more resources